Summary
According to substudy of the Action to Control Cardiovascular Risk in Diabetes [ACCORD; NCT00000620] trial, intensive glycemic control and combination fenofibrate + simvastatin therapy reduce the rate of diabetic retinopathy progression.
- Retinal Diseases
- Diabetes Mellitus
- Lipid Disorders
- Prevention & Screening
- Diabetes & Endocrinology Clinical Trials
- Hypertensive Disease
- © 2010 MD Conference Express
Tools
Table of contents
Cited By...
- No citing articles found.